Full text is available at the source.
Abstract
Diosgenin glucoside (DG) may offer therapeutic efficacy against radiation-induced thrombocytopenia (RIT).
- RIT is a significant complication of cancer radiotherapy that can limit treatment options.
- DG was selected for its potential benefits using a deep learning virtual screening method.
- The study explores both the effectiveness of DG and its underlying molecular mechanisms.
Simplified